Russell 2000 Index Newsroom

This Goldman Sachs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Benzinga2minutes ago

Leslie's Posts Weak Results, Joins Zoom Video And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Benzinga3minutes ago

Braze Analyst Ratings

Benzinga6minutes ago · Ratings

UroGen Pharma Presents New Data From A Long-Term Follow-Up Study Published In The Journal Of Urology Online To The OLYMPUS Trial Show Median Duration Of Response Of 4-Years In Patients Who Achieved A Complete Response With JELMYTO

Benzinga7minutes ago

Service Properties Trust Analyst Ratings

Benzinga7minutes ago · Ratings

This Eastman Chemical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Benzinga11minutes ago

Health Catalyst Analyst Ratings

Benzinga14minutes ago · Ratings

4 Analysts Assess Enanta Pharma: What You Need To Know

Benzinga14minutes ago

Piper Sandler Reiterates Overweight on Old National, Raises Price Target to $27

Benzinga14minutes ago · Ratings

Zoom's Tumble Leaves Mixed Picture for Collaboration Software

Seeking Alpha15minutes ago

Forecasting The Future: 4 Analyst Projections For MoneyLion

Benzinga15minutes ago

Old National Analyst Ratings

Benzinga16minutes ago · Ratings

Actuate Therapeutics to Be Added to Russell 2000 Index

GlobeNewswire16minutes ago

Piper Sandler Maintains Overweight on Merchants Bancorp, Raises Price Target to $52.5

Benzinga16minutes ago · Ratings

Merchants Bancorp Analyst Ratings

Benzinga18minutes ago · Ratings

Semtech Shares Are Trading Higher After the Company on Monday Reported Better-than-expected Q3 Financial Results and Issued Q4 Guidance With Its Midpoint Above Estimates.

Benzinga18minutes ago

PTC Therapeutics Analyst Ratings

Benzinga19minutes ago · Ratings

Enanta Pharma Analyst Ratings

Benzinga25minutes ago · Ratings

Abercrombie & Fitch Names Robert Ball As CFO, Effective November 20, 2024

Benzinga41minutes ago

Market-Moving News for November 26th

Benzinga46minutes ago